Skip to main content
Press Release

Dental Assistant Sentenced to 19 Months in Prison for Unlawful Prescription Opioid Pain Pills Distribution

For Immediate Release
U.S. Attorney's Office, District of New Jersey

CAMDEN, N.J. – A Pennsylvania woman was sentenced today to 19 months in prison for unlawfully distributing prescription opioid pain medication in the Philadelphia and South Jersey areas, U.S. Attorney Craig Carpenito announced.

Nancy Ayres, 44, a/k/a “Nancy Esslinger,” of Upper Chichester, Pennsylvania, previously pleaded guilty before U.S. District Judge Renee Marie Bumb to an information charging her with one count of distributing and possessing with intent to distribute oxycodone.  Judge Bumb imposed the sentence today in Camden federal court.  

According to the documents filed in the case and statements made in court:

Ayres is a dental assistant and has worked in several dental offices in the Philadelphia area and neighboring states. Beginning in at least December 2017, Ayres obtained prescriptions in close proximity to each other for large quantities of oxycodone pills from at least three different medical professionals.

Between April 2018 and June 2018, Ayres allegedly sold 1,044 15- and 20-milligram oxycodone tablets. Ayres made representations that she could obtain other prescription medications for sale, including muscle relaxers and medications for pain management, erectile dysfunction, and anxiety.

In addition to the prison term, Judge Bumb sentenced Ayres to three years of supervised release.

U.S. Attorney Carpenito credited special agents of the Drug Enforcement Administration’s New Jersey Division, under the direction of Special Agent in Charge Susan A. Gibson,; and the N.J. Attorney General’s Atlantic City Task Force, under the direction of Attorney General Gurbir S. Grewal, with the investigation leading to today’s sentencing.

The government is represented by Assistant U.S. Attorney Christina O. Hud of the Criminal Division in Camden.

Updated June 19, 2019

Drug Trafficking
Prescription Drugs
Press Release Number: 19-174